Medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic or enhance these effects, resulting in: Decreased appetite Reduced cravings Longer-lasting satiety after meals More stable blood sugar levels Over time, this leads to consistent weight loss , without the stress of crash dieting or extreme workouts
It is believed that the state after taking a meal (postprandial state) is pro-inflammatory and pro-oxidative, and the type of food mainly consumed affects the occurrence of OxS
Peptide Therapy may not be appropriate for everyone
Many incretin medicines are started gradually in studies or approved treatment plans to improve tolerability
Tirzepatide Tirzepatide is a dual agonist, activating both GLP-1 and GIP receptors
Some patients may need to continue the medication long-term to maintain their weight loss, while others may transition to a maintenance plan after achieving their desired results